Find your path to Andy
151 people in our graph share verified history with Andy — schools, employers, funds. One of them is your warm intro.
Detlev BiniszkiewiczunlockedAndy: together at AstraZeneca (2011)
×9Andy: together at AstraZeneca
Andy: together at Nagoya University
Andy: together at The University of Salford
About
A medicinal chemist with over 25 years in major pharma (Sanofi-Aventis, AstraZeneca) who leads scientific evaluation of investments at o2h Ventures. He is an inventor on 55+ publications and patents and serves as CSO of Opal Oncology.
Experience
- o2h venturesChief Scientific Officercurrent2014 — present
- o2h groupChief Scientific Officercurrent2014 — present
- Opal Oncology LimitedCSOcurrent2012 — presentCambridge, United Kingdom
- Andy Morley LTD3D Fragment Library Project Manager and Medicinal Chemistry Consultant2011 — 2013Cheshire
- AstraZenecaPrincipal Scientist Medicinal Chemistry2007 — 2011
- AstraZenecaTeam Leader, Medicinal Chemistry2000 — 2007
- AventisSection Manager1999 — 2000
- Rhone-Poulenc RorerSenior Research Fellow1998 — 1999
- Rhone-Poulenc RorerSenior Research Scientist1992 — 1998
Skills & more
GPCRs24Kinases11Lead Optimisation6Competitive Intelligence2Lead Generation4Project Generation1Medicinal Chemistry64Drug Discovery75Lead Change18Organic Synthesis16ADME9Organic Chemistry23
+12 more
Pharmaceutical ResearchProject ManagementOutsourcingDrug DesignHeterocyclic ChemistryHPLCParallel SynthesisChemistryPharmaceutical IndustryInflammationDMPKLifesciencesLanguages French · Japanese (elementary)
From Andy's professional profile.
Colleagues at O2h Ventures
Ajit Singh Guller
Marketing Manager at O2h Ventures
Catherine Beech
Independent Representative to the Investment Advisory Panel at O2h Ventures
Catherine Stace
VP - Strategic Relationships at O2h Ventures
Cengiz Tarhan
Independent Representative of the Investment Advisory Panel at O2h Ventures
Chris Reid
Venture Partner at O2h Ventures
Chris White
Vice President, Business Development at O2h Ventures
Dr Chris Torrance
Independent Representative of the Investment Advisory Panel at O2h Ventures
Gary Pitts
Compliance Consultant, Tetractys Limited at O2h Ventures
Frequently asked questions
- Who is Andy Morley?
- A medicinal chemist with over 25 years in major pharma (Sanofi-Aventis, AstraZeneca) who leads scientific evaluation of investments at o2h Ventures. He is an inventor on 55+ publications and patents and serves as CSO of Opal Oncology.
- Where does Andy Morley work?
- Andy Morley is Principal at O2h Ventures.
- Where did Andy Morley go to school?
- Andy Morley studied at Nagoya University (Post Doc, Asymmetric Hydrogenation); The University of Salford (Ph D, Acyl-nitroso cycloadditions); Nagoya University.
Same school
Also attended Nagoya University17
Praachi Jain MehtaChief of Staff at Augment VenturesHyunwoong KimAssociate at Airbus VenturesTomokatsu HongoDirector at Keio Innovation InitiativeTakayuki HiranoAssociate Investment Director at Taiho Ventures, LLCChen ZhuBoard Member Portfolio Companies at Aqua SparkHanh DoEntrepreneurship Training Program (ETP) Coordinator at Memorial Centre for Entrepreneurship
+ 11 more
Also attended The University of Salford24
Edward LamDirector of Finance at The Spartan GroupEssi HänninenOffice Manager at Innovestor VenturesJim WilkinsonCFO at Oxford Science EnterprisesJoe KellettInvestor at M33 GrowthEdward Vaughan LuiPartner, Head of Impact at Bridges Fund Management Ltd.Ben HarrisonSenior Consultant at Resonance
+ 18 more
Shared employers
Also worked at o2h group6
Sunil ShahInvestor at O2h VenturesCatherine StaceVP - Strategic Relationships at O2h VenturesGayathri SadasivamVP - Scientific Due Diligence at O2h VenturesRiddhi AhujaSenior Fund Operations Manager at O2h VenturesAjit Singh GullerMarketing Manager at O2h VenturesShubham TiwariDeal Flow Manager at O2h Ventures
Also worked at AstraZeneca91
Detlev BiniszkiewiczManaging Director at MPM BioImpactBriggs MorrisonEntrepreneur Partner at MPM BioImpactJung Lee, PhDVenture Partner at Adelphi Ventures Management, LlcJohan LundVenture Partner at ScietyIliam BarkinoInvestor at IndustrifondenSara JawadInvestor at Industrifonden
+ 85 more
Also worked at Aventis150
Steve LiapisManaging Director at Northpond VenturesWalter OlesiakOperating Partner at Remiges Ventures, Inc.Christine AylwardFounder & Managing Partner at Magnetic VenturesAlan WaltsVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD LongevityMatt VineSenior Associate at RRE Ventures
)
+ 144 more
